296 related articles for article (PubMed ID: 9445007)
1. A new system for stringent, high-titer vesicular stomatitis virus G protein-pseudotyped retrovirus vector induction by introduction of Cre recombinase into stable prepackaging cell lines.
Arai T; Matsumoto K; Saitoh K; Ui M; Ito T; Murakami M; Kanegae Y; Saito I; Cosset FL; Takeuchi Y; Iba H
J Virol; 1998 Feb; 72(2):1115-21. PubMed ID: 9445007
[TBL] [Abstract][Full Text] [Related]
2. Inducible, high-level production of infectious murine leukemia retroviral vector particles pseudotyped with vesicular stomatitis virus G envelope protein.
Yang Y; Vanin EF; Whitt MA; Fornerod M; Zwart R; Schneiderman RD; Grosveld G; Nienhuis AW
Hum Gene Ther; 1995 Sep; 6(9):1203-13. PubMed ID: 8527479
[TBL] [Abstract][Full Text] [Related]
3. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes.
Ory DS; Neugeboren BA; Mulligan RC
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11400-6. PubMed ID: 8876147
[TBL] [Abstract][Full Text] [Related]
4. High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells.
Mochizuki H; Schwartz JP; Tanaka K; Brady RO; Reiser J
J Virol; 1998 Nov; 72(11):8873-83. PubMed ID: 9765432
[TBL] [Abstract][Full Text] [Related]
5. Dose-dependent transduction of vesicular stomatitis virus G protein-pseudotyped retrovirus vector into human solid tumor cell lines and murine fibroblasts.
Arai T; Takada M; Ui M; Iba H
Virology; 1999 Jul; 260(1):109-15. PubMed ID: 10405362
[TBL] [Abstract][Full Text] [Related]
6. Retrovirus vectors designed for efficient transduction of cytotoxic or cytostatic genes.
Ui M; Takada M; Arai T; Matsumoto K; Yamada K; Nakahata T; Nishiwaki T; Furukawa Y; Tokino T; Nakamura Y; Iba H
Gene Ther; 1999 Oct; 6(10):1670-8. PubMed ID: 10516715
[TBL] [Abstract][Full Text] [Related]
7. Pseudotransduction of hepatocytes by using concentrated pseudotyped vesicular stomatitis virus G glycoprotein (VSV-G)-Moloney murine leukemia virus-derived retrovirus vectors: comparison of VSV-G and amphotropic vectors for hepatic gene transfer.
Liu ML; Winther BL; Kay MA
J Virol; 1996 Apr; 70(4):2497-502. PubMed ID: 8642678
[TBL] [Abstract][Full Text] [Related]
8. VSV-G-pseudotyped retroviral packaging through adenovirus-mediated inducible gene expression.
Yoshida Y; Emi N; Hamada H
Biochem Biophys Res Commun; 1997 Mar; 232(2):379-82. PubMed ID: 9125185
[TBL] [Abstract][Full Text] [Related]
9. Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein.
Bartz SR; Vodicka MA
Methods; 1997 Aug; 12(4):337-42. PubMed ID: 9245614
[TBL] [Abstract][Full Text] [Related]
10. Use of a recombinant murine cytomegalovirus expressing vesicular stomatitis virus G protein to pseudotype retroviral vectors.
Manning WC; Murphy JE; Jolly DJ; Mento SJ; Ralston RO
J Virol Methods; 1998 Jul; 73(1):31-9. PubMed ID: 9705172
[TBL] [Abstract][Full Text] [Related]
11. Production of vesicular stomatitis virus G glycoprotein (VSV-G) pseudotyped retroviral vectors.
Lo HL; Yee JK
Curr Protoc Hum Genet; 2007 Jan; Chapter 12():Unit 12.7. PubMed ID: 18428407
[TBL] [Abstract][Full Text] [Related]
12. Transduction efficiency of pantropic retroviral vectors is controlled by the envelope plasmid to vector plasmid ratio.
Chen Y; Miller WM; Aiyar A
Biotechnol Prog; 2005; 21(1):274-82. PubMed ID: 15903266
[TBL] [Abstract][Full Text] [Related]
13. Generation of packaging cell lines for pseudotyped retroviral vectors of the G protein of vesicular stomatitis virus by using a modified tetracycline inducible system.
Chen ST; Iida A; Guo L; Friedmann T; Yee JK
Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10057-62. PubMed ID: 8816750
[TBL] [Abstract][Full Text] [Related]
14. Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir.
Howard BD; Boenicke L; Schniewind B; Henne-Bruns D; Kalthoff H
Cancer Gene Ther; 2000 Jun; 7(6):927-38. PubMed ID: 10880025
[TBL] [Abstract][Full Text] [Related]
15. Targeted transduction patterns in the mouse brain by lentivirus vectors pseudotyped with VSV, Ebola, Mokola, LCMV, or MuLV envelope proteins.
Watson DJ; Kobinger GP; Passini MA; Wilson JM; Wolfe JH
Mol Ther; 2002 May; 5(5 Pt 1):528-37. PubMed ID: 11991743
[TBL] [Abstract][Full Text] [Related]
16. Generation of high-titer pseudotyped retroviral vectors with very broad host range.
Yee JK; Friedmann T; Burns JC
Methods Cell Biol; 1994; 43 Pt A():99-112. PubMed ID: 7823872
[TBL] [Abstract][Full Text] [Related]
17. Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus.
Emi N; Friedmann T; Yee JK
J Virol; 1991 Mar; 65(3):1202-7. PubMed ID: 1847450
[TBL] [Abstract][Full Text] [Related]
18. Lack of superinfection interference in retroviral vector producer cells.
Vogt B; Roscher S; Abel B; Hildinger M; Lamarre A; Baum C; von Laer D
Hum Gene Ther; 2001 Mar; 12(4):359-65. PubMed ID: 11242528
[TBL] [Abstract][Full Text] [Related]
19. High-efficiency gene transfer into CD34+ cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G.
Akkina RK; Walton RM; Chen ML; Li QX; Planelles V; Chen IS
J Virol; 1996 Apr; 70(4):2581-5. PubMed ID: 8642689
[TBL] [Abstract][Full Text] [Related]
20. Superior transduction of mouse hematopoietic stem cells with 10A1 and VSV-G pseudotyped retrovirus vectors.
Barrette S; Douglas J; Orlic D; Anderson SM; Seidel NE; Miller AD; Bodine DM
Mol Ther; 2000 Apr; 1(4):330-8. PubMed ID: 10933951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
